Since KRAS G12C mutation is not the most frequent in colorectal cancers, unlike lung cancer, considerable interest is focused on other potential KRAS inhibitors, particularly KRAS G12D, which represents the most common KRAS mutation in colorectal cancer. The gene discussed is KRAS; the disease is lung carcinoma.